Literature DB >> 18725175

Calcium, calcium-sensing receptor and colon cancer.

James F Whitfield1.   

Abstract

There is much evidence that dietary Ca(2+) loading reduces colon cell proliferation and carcinogenesis in humans and rodents, but during carcinogenesis it becomes ineffective or even tumor-promoting. We are beginning to see how Ca(2+) balances the continuous massive cell production in colon crypts by driving the terminal differentiation and eventually the apoptosis of the cells mainly on the mucosal surface, and how this Ca(2+) control is lost during colon carcinogenesis. The rapid proliferation of the transit-amplifying (TA) progeny of the colon stem cells is driven by the so-called "Wnt" signaling mechanism, which involves the stimulation of proliferogenic genes such as those for c-Myc and cyclin D1 and the silencing of the gene for the cell cycle-stopping p21(Cip1/WAF1) protein by nuclear beta-catenin*Tcf-4 complexes. TA cells avoid mitotic damage and premature apoptosis by expressing the protein survivin. It appears that TA cell cycling stops and terminal differentiation starts when the cells reach a higher level in the crypt where there is enough lumenal Ca(2+) to stimulate the expression and activation of CaSRs (Ca(2+)-sensing receptors), the signals from which stimulate the expression of E-cadherin. Along with this, the APC (adenomatous polyposis coli) protein appears and some of it enters the nucleus. There it makes the TA cells susceptible to the eventual apoptotic balancing by stopping survivin expression and the beta-catenin*Tcf-4 complex from driving further cell cycling by releasing beta-catenin from the nucleus, and delivering it to cytoplasmic APC*axin*GSK-3beta complexes for ultimate proteasomal destruction. Cytoplasmic beta-catenin is then prevented from returning to the nucleus by either being intercepted and destroyed by APC*axin*GSK-3beta complexes or locked by the emerging E-cadherin into membrane adherens junctions which tie the cell into the sheet of proliferatively shut-down cells with APC-dependent cytoskeletons moving to the mouth of the crypt and onto the flat mucosal surface. A common first step in sporadic colon carcinogenesis is the loss of functional APC which disorients upwardly directed migration and causes the retention of nuclear beta-catenin and proliferogenic beta-catenin*Tcf-4 complexes as well as genomic instability. Eventually the balance between cell proliferation and terminal differentiation and death is radically tipped in favour of proliferation by the appearance of apoptosis-resistant, survivin-expressing clones of Ca(2+)-insensitive cells which are locked into the proliferative, mutation-prone mode because of CaSR-disabling gene mutations which prevent the stimulation of E-cadherin expression and terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725175     DOI: 10.1016/j.canlet.2008.07.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  31 in total

1.  Microdevice to capture colon crypts for in vitro studies.

Authors:  Yuli Wang; Rahul Dhopeshwarkar; Rani Najdi; Marian L Waterman; Christopher E Sims; Nancy Allbritton
Journal:  Lab Chip       Date:  2010-04-07       Impact factor: 6.799

2.  The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma.

Authors:  Kazunori Shibao; Michael J Fiedler; Jun Nagata; Noritaka Minagawa; Keiji Hirata; Yoshifumi Nakayama; Yasuko Iwakiri; Michael H Nathanson; Koji Yamaguchi
Journal:  Cell Calcium       Date:  2010-11-13       Impact factor: 6.817

3.  The functional expression of calcium-sensing receptor in the differentiated THP-1 cells.

Authors:  Yu-hui Xi; Hong-zhu Li; Wei-hua Zhang; Li-na Wang; Li Zhang; Yan Lin; Shu-zhi Bai; Hong-xia Li; Ling-yun Wu; Rui Wang; Chang-qing Xu
Journal:  Mol Cell Biochem       Date:  2010-05-15       Impact factor: 3.396

4.  New Therapeutics Targeting Colon Cancer Stem Cells.

Authors:  Arun Thenappan; Ying Li; Kirti Shetty; Lynt Johnson; E P Reddy; Lopa Mishra
Journal:  Curr Colorectal Cancer Rep       Date:  2009-10-01

5.  Alterations in the developing testis transcriptome following embryonic vinclozolin exposure.

Authors:  Tracy M Clement; Marina I Savenkova; Matthew Settles; Matthew D Anway; Michael K Skinner
Journal:  Reprod Toxicol       Date:  2010-06-08       Impact factor: 3.143

6.  Dysregulation of cadherins in the intercalated disc of the spontaneously hypertensive stroke-prone rat.

Authors:  Margaret Anne Craig; Martin W McBride; Godfrey Smith; Sarah J George; Andrew Baker
Journal:  J Mol Cell Cardiol       Date:  2010-02-06       Impact factor: 5.000

7.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

8.  Human colonic crypts in culture: segregation of immunochemical markers in normal versus adenoma-derived.

Authors:  Michael K Dame; Yan Jiang; Henry D Appelman; Kelly D Copley; Shannon D McClintock; Muhammad Nadeem Aslam; Durga Attili; B Joseph Elmunzer; Dean E Brenner; James Varani; D Kim Turgeon
Journal:  Lab Invest       Date:  2013-12-23       Impact factor: 5.662

Review 9.  Minireview: the intimate link between calcium sensing receptor trafficking and signaling: implications for disorders of calcium homeostasis.

Authors:  Gerda E Breitwieser
Journal:  Mol Endocrinol       Date:  2012-06-28

10.  Growth-inhibitory effects of a mineralized extract from the red marine algae, Lithothamnion calcareum, on Ca(2+)-sensitive and Ca(2+)-resistant human colon carcinoma cells.

Authors:  Muhammad Nadeem Aslam; Narasimharao Bhagavathula; Tejaswi Paruchuri; Xin Hu; Subhas Chakrabarty; James Varani
Journal:  Cancer Lett       Date:  2009-04-24       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.